A-Ret Gel 0.1% Menarini — Research Summary
A-Ret Gel 0.1% Menarini is a pharmaceutical-grade tretinoin formulation developed for laboratory research applications. Tretinoin is a synthetic vitamin A derivative (all-trans retinoic acid) that serves as a valuable research tool for investigating retinoid receptor pathways, cellular differentiation mechanisms, and epithelial tissue responses in controlled experimental conditions. This Menarini-manufactured gel provides researchers with a standardised topical formulation containing 0.1% tretinoin concentration for consistent study protocols. Tretinoin functions as a ligand for retinoic acid receptors (RARs) and retinoid X receptors (RXRs), making it essential for transcriptional regulation studies and cellular biology research. The gel vehicle offers advantages for in-vitro studies requiring controlled compound delivery and absorption characteristics. Researchers at Stroid UK Shop utilise pharmaceutical-grade formulations like A-Ret Gel for investigating dermatological research models and cellular response mechanisms.
Laboratory Applications
Research scientists examine tretinoin’s effects on keratinocyte proliferation, differentiation pathways, and gene expression profiles in cellular models. The compound demonstrates significant activity in modulating cell cycle regulation, apoptosis mechanisms, and extracellular matrix remodelling processes. Studies investigate tretinoin’s influence on collagen synthesis pathways, sebocyte function, and inflammatory mediator expression in tissue culture systems. The gel formulation enables researchers to evaluate penetration kinetics, stability profiles, and bioavailability characteristics under controlled laboratory conditions. Comparative studies with other retinoids available in our tretinoin research collection provide valuable insights into structure-activity relationships. Additional research applications include investigating photodamage repair mechanisms, wound healing processes, and age-related cellular changes. Many laboratories combine tretinoin research with studies using SARMs compounds or research peptides for comprehensive molecular pathway analysis.
Product Specifications
| Active Compound | Tretinoin (All-trans retinoic acid) |
|---|---|
| Concentration | 0.1% w/w |
| Formulation | Topical gel |
| Manufacturer | Menarini |
| CAS Number | 302-79-4 |
| Molecular Formula | C₂₀H₂₈O₂ |
| Molecular Weight | 300.44 g/mol |
| Storage | 2-8°C, protect from light |
Research Compliance
A-Ret Gel 0.1% Menarini is manufactured exclusively for in-vitro laboratory research purposes and scientific investigation. This pharmaceutical-grade tretinoin formulation is not approved for human consumption, therapeutic use, or any clinical application. Researchers must maintain proper laboratory safety protocols and disposal procedures when handling retinoid compounds. The product requires appropriate storage conditions and handling expertise for maintaining compound stability and research integrity. All studies must comply with institutional review protocols and applicable research regulations.
